458 related articles for article (PubMed ID: 12045256)
21. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
[TBL] [Abstract][Full Text] [Related]
22. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas.
Kageyama H; Funahashi H; Hirayama M; Takenoya F; Kita T; Kato S; Sakurai J; Lee EY; Inoue S; Date Y; Nakazato M; Kangawa K; Shioda S
Regul Pept; 2005 Mar; 126(1-2):67-71. PubMed ID: 15620416
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats.
Kamegai J; Wakabayashi I; Kineman RD; Frohman LA
J Neuroendocrinol; 1999 Apr; 11(4):299-306. PubMed ID: 10223284
[TBL] [Abstract][Full Text] [Related]
24. Changes in expression of the genes for the leptin receptor and the growth hormone-releasing peptide/ghrelin receptor in the hypothalamic arcuate nucleus with long-term manipulation of adiposity by dietary means.
Kurose Y; Iqbal J; Rao A; Murata Y; Hasegawa Y; Terashima Y; Kojima M; Kangawa K; Clarke IJ
J Neuroendocrinol; 2005 Jun; 17(6):331-40. PubMed ID: 15929739
[TBL] [Abstract][Full Text] [Related]
25. Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.
Rigamonti AE; Cella SG; Giordani C; Bonomo SM; Giunta M; Sartorio A; Muller E
Neuroendocrinology; 2006; 84(2):115-22. PubMed ID: 17106185
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system.
Arvat E; Gianotti L; Giordano R; Broglio F; Maccario M; Lanfranco F; Muccioli G; Papotti M; Graziani A; Ghigo E; Deghenghi R
Endocrine; 2001 Feb; 14(1):35-43. PubMed ID: 11322500
[TBL] [Abstract][Full Text] [Related]
27. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
28. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content.
Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD
Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428
[TBL] [Abstract][Full Text] [Related]
29. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
Lawrence CB; Snape AC; Baudoin FM; Luckman SM
Endocrinology; 2002 Jan; 143(1):155-62. PubMed ID: 11751604
[TBL] [Abstract][Full Text] [Related]
30. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor.
Zizzari P; Halem H; Taylor J; Dong JZ; Datta R; Culler MD; Epelbaum J; Bluet-Pajot MT
Endocrinology; 2005 Sep; 146(9):3836-42. PubMed ID: 15919752
[TBL] [Abstract][Full Text] [Related]
31. Central actions of the nonpeptide growth hormone secretagogue GHS-25.
Bailey AR; Gilliver L; Leng G; Smith RG
Endocrine; 2001 Feb; 14(1):15-9. PubMed ID: 11322497
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686.
Nagamine J; Nagata R; Seki H; Nomura-Akimaru N; Ueki Y; Kumagai K; Taiji M; Noguchi H
J Endocrinol; 2001 Dec; 171(3):481-9. PubMed ID: 11739014
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.
Asakawa A; Inui A; Kaga T; Katsuura G; Fujimiya M; Fujino MA; Kasuga M
Gut; 2003 Jul; 52(7):947-52. PubMed ID: 12801949
[TBL] [Abstract][Full Text] [Related]
34. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats.
Kamegai J; Tamura H; Shimizu T; Ishii S; Sugihara H; Wakabayashi I
Diabetes; 2001 Nov; 50(11):2438-43. PubMed ID: 11679419
[TBL] [Abstract][Full Text] [Related]
35. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor.
Kojima M; Hosoda H; Matsuo H; Kangawa K
Trends Endocrinol Metab; 2001 Apr; 12(3):118-22. PubMed ID: 11306336
[TBL] [Abstract][Full Text] [Related]
36. Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor.
Kojima M; Hosoda H; Kangawa K
Horm Res; 2001; 56 Suppl 1():93-7. PubMed ID: 11786694
[TBL] [Abstract][Full Text] [Related]
37. Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion.
Farhy LS; Veldhuis JD
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1649-63. PubMed ID: 15718392
[TBL] [Abstract][Full Text] [Related]
38. Presence of ghrelin in normal and adenomatous human pituitary.
Korbonits M; Kojima M; Kangawa K; Grossman AB
Endocrine; 2001 Feb; 14(1):101-4. PubMed ID: 11322490
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf Rat.
Kamegai J; Wakabayashi I; Miyamoto K; Unterman TG; Kineman RD; Frohman LA
Neuroendocrinology; 1998 Nov; 68(5):312-8. PubMed ID: 9822798
[TBL] [Abstract][Full Text] [Related]
40. Chronic changes in peripheral growth hormone levels do not affect ghrelin stomach mRNA expression and serum ghrelin levels in three transgenic mouse models.
Nass R; Liu J; Hellmann P; Coschigano KT; Gaylinn B; Berryman DE; Kopchick JJ; Thorner MO
J Neuroendocrinol; 2004 Aug; 16(8):669-75. PubMed ID: 15271059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
